Datasets for the validation of the "in vivo" siRNA-silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice.
Hueso M, De Ramon L, Navarro E, Ripoll E, Cruzado JM, Grinyo JM, Torras J.
Hueso M, et al. Among authors: navarro e.
Data Brief. 2016 Nov 19;9:1105-1112. doi: 10.1016/j.dib.2016.11.045. eCollection 2016 Dec.
Data Brief. 2016.
PMID: 27924297
Free PMC article.
Data presented in this Data in Brief article correspond to the article "in vivo" silencing of CD40 reduces progression of experimental atherogenesis through a NFkappaB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis" (M. Hueso, L. De Ramon …
Data presented in this Data in Brief article correspond to the article "in vivo" silencing of CD40 reduces progression of experimental ather …